The core activity of DeepVax GmbH is the development, manufacture and marketing of innovative therapeutic vaccines against chronic inflammatory diseases, obesity, aging and cancer.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered7
Therapeutic vaccines
Therapeutic vaccines based on optimised Virus-like Particles (VLPs) for active immunisation against chronic diseases and disease-causing endogenous molecules.
Vaccines against inflammation
Vaccines against chronic inflammation in skin, lungs and heart, developed based on clinically validated target structures and molecular modelling.
Vaccines against obesity
Vaccines to support novel therapies against obesity, developed with molecular modelling for more affordable use.
Vaccines against aging and Alzheimer
Vaccines against age-associated inflammatory processes and Alzheimer’s disease, with preclinically tested candidates for neurodegeneration.
Personalised cancer vaccines
Personalised cancer vaccines based on VLPs, developed using immunopeptidomics and Whole-Exome-Sequencing to identify patient-specific tumour antigens.
Universal cancer vaccines
Universal cancer vaccines with VLPs and Microcrystalline Tyrosine as an immunostimulant, designed for human applications and preclinical models.
VLP-based vaccine platform
Virus-like particle platform for the development of tailored therapeutic vaccines with immunologically and structurally optimised nanoparticles.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.